# Zafirlukast

NDC: 55111-626
Generic name: Zafirlukast
Labeler / Manufacturer: Dr. Reddys Laboratories Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20101118

FDA application: ANDA090372

## Active ingredients

- ZAFIRLUKAST: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"55111-626"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=55111-626
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6ccb96af-2647-9206-5eee-49a825d32488
